Chimerix gets fast track status; Richter inks R&D deal with Orion;

 @FierceBiotech: In case you missed it: Medtronic, Edwards headline this year's ACC news. Roundup | Follow @FierceBiotech

@JohnCFierce: Another high flying cancer drug developer looks like a takeover. Puma turns Pfizer castoff into gold. Report | Follow @JohnCFierce

@RyanMFierce: Shire has acquired Premacure AB for drug against rare eye disease. Release | Follow @RyanMFierce

> Chimerix announced that the FDA granted Fast Track designation for CMX001 for the prevention of cytomegalovirus (CMV) infection. Release

> Hungary's Richter inked an R&D cooperation deal with Orion Corporation. Story

Pharma News

@FiercePharma: That Novartis probe is responding to criminal complaints about lack of disclosure, per Bloomberg. More | Follow @FiercePharma

@EricPFierce: Baxter Intl. investing more into international manufacturing, this time in Puerto Rico but it means 400 fewer jobs. Article | Follow @EricPFierce

> ProPublica: Pharma's doc-payment disclosures top $2B. Article

> Swiss prosecutor weighs charges against Novartis directors, ex-chairman. News

> Merck gets green light to continue Vytorin outcomes trial. More

Medical Device News

 @FierceMedDev: Stryker slapped with FDA warning letter. More | Follow @FierceMedDev

 @MarkHFierce: St. Jude Medical is releasing a next-gen stent imaging system in Japan, hoping to propel major interest. Article | Follow @MarkHFierce

 @DamianFierce: Cancer Genetics IPO target keeps falling, from $41.9M to $29.3M to $20.1M and, now, just $14.3M. Report | Follow @DamianFierce

> Decision Diagnostics challenges J&J with diabetes test. Story

> Early-stage Alzheimer's blood test on U.K. team's agenda. More

> Crescendo rolls out iPhone app for RA Dx. Item

Pharma Manufacturing News

> Marken pushes international expansion with warehouse in China. Item

> Pfizer, Glaxo, others give Interpol money to fight counterfeiters. Report

> Catalent deals target China from 2 directions. Story

> FDA slaps vaginal gel maker for sloppy manufacturing, no NDA. More

Biotech Research News

@EmilyMFierce: The origin of ovarian cancer has evaded scientists, but researchers at Cornell may have found a possible source. More | Follow @EmilyMFierce

> New therapy shows promise in treating inflammatory breast cancer. Report

> Deleting a gene in mice prevents obesity. Article

> Salt may be risk factor for MS, other autoimmune diseases. Story

> Buildup of unwanted proteins may lead to dementia. Item

And Finally… The use of antipsychotics in the elderly has been linked to an increased risk of stroke, according to a new study published in Biological Psychiatry. Release


Suggested Articles

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.